JOP20200066B1 - طريقة لتحضير أحماض ألفا هالو ألكانويك لا تماثلية - Google Patents

طريقة لتحضير أحماض ألفا هالو ألكانويك لا تماثلية

Info

Publication number
JOP20200066B1
JOP20200066B1 JOJO/P/2020/0066A JOP20200066A JOP20200066B1 JO P20200066 B1 JOP20200066 B1 JO P20200066B1 JO P20200066 A JOP20200066 A JO P20200066A JO P20200066 B1 JOP20200066 B1 JO P20200066B1
Authority
JO
Jordan
Prior art keywords
context
preparing asymmetric
haloalkanoic acids
alpha
asymmetric alpha
Prior art date
Application number
JOJO/P/2020/0066A
Other languages
English (en)
Inventor
Egger Julian
Spelberg Markus
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of JOP20200066A1 publication Critical patent/JOP20200066A1/ar
Application granted granted Critical
Publication of JOP20200066B1 publication Critical patent/JOP20200066B1/ar

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/002Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by oxidation/reduction reactions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/40Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y308/00Hydrolases acting on halide bonds (3.8)
    • C12Y308/01Hydrolases acting on halide bonds (3.8) in C-halide substances (3.8.1)
    • C12Y308/01002(S)-2-Haloacid dehalogenase (3.8.1.2)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

الملخص يتعلق هذا الاختراع بطريقة للحلمأة الانتقائية لبُد من حمض ألفا هالو ألكانويك وفقاً للصيغة (I) باستخدام متعدد ببتيد له فعالية ديهالوجيناز يشتمل على سياق حمض أميني كما هو مذكور في السياق برقم تعريف 1 أو السياق برقم تعريف 4 أو سياق له نسبة تطابق لا تقل عن 80? مع السياقات المذكورة، كما يتعلق باستخدام الطريقة المذكورة.
JOJO/P/2020/0066A 2017-09-28 2020-04-27 طريقة لتحضير أحماض ألفا هالو ألكانويك لا تماثلية JOP20200066B1 (ar)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17193736.0A EP3461900A1 (en) 2017-09-28 2017-09-28 Method for the preparation of chiral alpha haloalkanoic acids
PCT/EP2018/075752 WO2019063463A2 (en) 2017-09-28 2018-09-24 PROCESS FOR PREPARING CHIRAL ALPHA HALOALCANOIC ACIDS

Publications (2)

Publication Number Publication Date
JOP20200066A1 JOP20200066A1 (ar) 2020-04-27
JOP20200066B1 true JOP20200066B1 (ar) 2024-12-22

Family

ID=60083756

Family Applications (1)

Application Number Title Priority Date Filing Date
JOJO/P/2020/0066A JOP20200066B1 (ar) 2017-09-28 2020-04-27 طريقة لتحضير أحماض ألفا هالو ألكانويك لا تماثلية

Country Status (21)

Country Link
US (1) US11053518B2 (ar)
EP (3) EP3461900A1 (ar)
JP (2) JP2020536523A (ar)
KR (2) KR102697846B1 (ar)
CN (1) CN111094578A (ar)
AR (1) AR113146A1 (ar)
AU (1) AU2018340299B2 (ar)
BR (1) BR112020006680A2 (ar)
CA (1) CA3076687A1 (ar)
CL (2) CL2020000802A1 (ar)
CO (1) CO2020003870A2 (ar)
IL (1) IL273513B2 (ar)
JO (1) JOP20200066B1 (ar)
MX (1) MX2020003729A (ar)
MY (1) MY200971A (ar)
PE (1) PE20201413A1 (ar)
SG (1) SG11202002476UA (ar)
TW (1) TWI799450B (ar)
UA (1) UA128060C2 (ar)
UY (1) UY37908A (ar)
WO (1) WO2019063463A2 (ar)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5931690A (ja) * 1982-08-11 1984-02-20 Unitika Ltd 光学活性乳酸の製造方法
DE3587212T2 (de) * 1984-10-25 1993-09-30 Ici Plc Enzyme.
US5154738A (en) 1989-09-12 1992-10-13 Advanced Separation Technologies, Inc. Chiral separation media
JPH04325096A (ja) * 1991-04-25 1992-11-13 Maruzen Petrochem Co Ltd (R)−2−ハロプロピオン酸および(R)−2−ハロ−n−酪酸の製造法
CN103509778B (zh) * 2012-06-28 2016-04-13 中国科学院大连化学物理研究所 一种卤代酸脱卤酶的提取纯化方法
CN107022556B (zh) * 2017-03-29 2019-10-29 中山大学 一种用枯草芽孢杆菌工程菌降解1,2,3-三氯丙烷的方法

Also Published As

Publication number Publication date
WO2019063463A2 (en) 2019-04-04
JP7568776B2 (ja) 2024-10-16
MX2020003729A (es) 2020-08-03
KR20200060388A (ko) 2020-05-29
IL273513B2 (en) 2024-09-01
CA3076687A1 (en) 2019-04-04
CL2020000802A1 (es) 2020-09-21
EP3786300A1 (en) 2021-03-03
EP3461900A1 (en) 2019-04-03
CN111094578A (zh) 2020-05-01
IL273513B1 (en) 2024-05-01
RU2020114761A (ru) 2021-10-28
KR102697846B1 (ko) 2024-08-26
RU2020114761A3 (ar) 2022-04-01
CO2020003870A2 (es) 2020-04-24
TW201920057A (zh) 2019-06-01
EP3688178A2 (en) 2020-08-05
CL2021002058A1 (es) 2022-02-25
AR113146A1 (es) 2020-01-29
BR112020006680A2 (pt) 2020-10-06
JOP20200066A1 (ar) 2020-04-27
UY37908A (es) 2019-04-30
PE20201413A1 (es) 2020-12-07
US11053518B2 (en) 2021-07-06
AU2018340299A1 (en) 2020-03-19
IL273513A (en) 2020-05-31
JP2023093674A (ja) 2023-07-04
US20200277633A1 (en) 2020-09-03
SG11202002476UA (en) 2020-04-29
KR20230128132A (ko) 2023-09-01
UA128060C2 (uk) 2024-03-27
AU2018340299B2 (en) 2023-10-19
TWI799450B (zh) 2023-04-21
WO2019063463A3 (en) 2019-05-02
JP2020536523A (ja) 2020-12-17
MY200971A (en) 2024-01-26

Similar Documents

Publication Publication Date Title
ZA202308519B (en) Anti-vegf protein compositions and methods for producing the same
MX383537B (es) Mutantes de proteína f de rsv.
JOP20200323A1 (ar) طرق لتصنيع تركيبات الأحماض الأمينية
PE20170955A1 (es) Nuevas proteinas inhibidoras de insectos
BR112016026842A2 (pt) preparação compreendendo fator viii e peptídeos de fator de von willebrand
BR112017020308A2 (pt) udp-glicosiltransferases
AR120721A2 (es) Péptidos y composiciones para el tratamiento de daño articular
WO2015107363A3 (en) Mycobacterial antigen composition
PL415888A1 (pl) Sposób wytwarzania insuliny i jej pochodnych oraz peptyd hybrydowy stosowany w tym sposobie
PH12017502323A1 (en) Novel xylanase
MX362058B (es) Péptido pntx(19) sintético, composición farmacéutica y uso.
EA201690966A1 (ru) Новое соединение для лечения тяжелой гипогликемии
JOP20200066B1 (ar) طريقة لتحضير أحماض ألفا هالو ألكانويك لا تماثلية
WO2019103512A3 (ko) 목적 단백질의 발현 효율을 증진시키기 위한 신규한 펩타이드 및 이를 포함하는 융합 단백질
EA201592019A1 (ru) Лиофилизат, содержащий циклический пептид формулы x-gqretpegaeakpwy-x
PH12017550079A1 (en) Composition for improving memory, learning ability and cognition
AR102120A1 (es) Interferón modificado con inmunogenicidad reducida
BR112017019625A2 (pt) udp-glicosiltransferases
MX2018011109A (es) Composicion farmaceutica para el tratamiento y/o prevencion de cancer.
BR112017000146A2 (pt) micro-organismo recombinante do gênero escherichia produzindo ácido quinolínico, e método de produção de ácido quinolínico